The primary hyperlipoproteinemias.
D001796:Blood Protein Disorders / Q000175:diagnosis / Q000628:therapy; D002784:Cholesterol / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002914:Chylomicrons / Q000097:blood; D002994:Clofibrate / Q000627:therapeutic use; D006801:Humans; D006937:Hypercholesterolemia / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D006949:Hyperlipidemias / Q000175:diagnosis / Q000628:therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008074:Lipoproteins / Q000097:blood*; D008077:Lipoproteins, LDL / Q000097:blood; D009539:Nicotinic Acids / Q000627:therapeutic use; D013974:Thyroxine / Q000627:therapeutic use; D014280:Triglycerides / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism
D002914:Chylomicrons; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D008077:Lipoproteins, LDL; D009539:Nicotinic Acids; D014280:Triglycerides; D002792:Cholestyramine Resin; D002784:Cholesterol; D002994:Clofibrate; D013974:Thyroxine